Cyclophosphamide (C): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer | 2 |
| ER+/HER2- Breast Cancer | 1 |
Recruiting trials involving Cyclophosphamide (C)
- Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
- Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
Common questions
How many recruiting trials involve Cyclophosphamide (C)?
2 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.